Athira Pharma, Inc. IPO Research Information

Athira Pharma, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Athira Pharma, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Athira Pharma, Inc.	ATHA - NASDAQ	$15.00-$17.00	$17.00	$19.95	12 million	9/18/2020
Underwriter(s): Goldman Sachs, Jefferies, Stifel
Co-Manager(s): JMP Securities
Industry: Health Care
Filing(s): Filed 2020-08-27 Terms Added 2020-09-14

Athira Pharma, Inc. Quote & Chart - Click for current quote - ATHA

About Athira Pharma, Inc. (adapted from Athira Pharma, Inc. prospectus):
They are a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ATHA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.